12,5 %Breast cancer is the leading cancer in Kenya, with an incidence of 12.5%.
Kenyacancer du seinpublié 2023The Pan African medical journalPubMeddocument de 14 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
6 677 evidences · page 31 / 268
12,5 %Breast cancer is the leading cancer in Kenya, with an incidence of 12.5%.
Kenyacancer du seinpublié 2023The Pan African medical journalPubMeddocument de 14 observations
97 %97% of the 67 Cryptococcus neoformans isolates tested were susceptible to fluconazole.
Kenyaméningite cryptococciquepublié 2011Mycoseseurope_pmcdocument de 5 observationsDOI 10.1111/j.1439-0507.2010.01946.x
6 %Babies born to primigravidae who received Maloprim had 6% low birth weight compared to 22% in those who received placebo.
Kenyapaludismepublié 1989Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 7 observations
78 %The 1-year relative survival for prostate cancer patients in sub-Saharan Africa was 78.0%.
Kenyacancer de la prostateobservé 2005-2015publié 2021Cancer causes & control : CCCeurope_pmcdocument de 7 observationsDOI 10.1007/s10552-021-01453-x
92,2 %The positive predictive value of microscopy for detecting P. falciparum parasitaemia was 92.2% in asymptomatic children aged 7–14 years in western Kenya.
Kenyapaludismepublié 2022Malaria journalPubMeddocument de 6 observations
12 439 copies/mLThe mean HIV viral load among women with detectable viral load was 12,439 copies/mL.
KenyaVIH/sidapublié 2025International journal of STD & AIDSPubMeddocument de 8 observations
26,6 %Among 2796 reviewed COVID-19 case records in Kenya, 743 (26.6%) were residents of Nairobi City County.
KenyaCOVID-19publié 2022Journal of global healthPubMeddocument de 24 observations
5,6 %Sporozoite prevalence was 5.6% in Anopheles funestus.
Kenyapaludismeobservé 2020publié 2022Parasites & vectorsPubMeddocument de 6 observations
19 %Respiratory syncytial virus (RSV) was identified as a main etiology in 19% of pneumonia deaths among pediatric deaths investigated from 2014 to 2015.
Kenyapneumonie · respiratory syncytial virus (RSV)observé 2014 to 2015publié 2021The Pediatric infectious disease journalPubMeddocument de 12 observations
58,2 %Among people with HIV, HIV/AIDS/tuberculosis was the leading cause of death, accounting for 319 deaths (58.2%) in western Kenya.
KenyaHIV/AIDS/tuberculosispublié 2026Global health actionPubMeddocument de 7 observations
8,5 %HIV prevalence was 8.5% among men who have sex with men who solely met partners via physical sites (PMSM) in Kenya.
KenyaVIH/sidaobservé 2019publié 2020Journal of the International AIDS SocietyPubMeddocument de 12 observations
36,7 per_100000In Kampala, Uganda, the age-standardized incidence rate of oesophageal cancer was 36.7 per 100,000 in males and 24.8 per 100,000 in females between 2004 and 2008.
Kenyaoesophageal cancerobservé 2004–2008publié 2015Cancer epidemiologyeurope_pmcdocument de 10 observationsDOI 10.1016/j.canep.2015.01.001
151 participantsThe study included 151 HIV-1-seronegative Kenyan female sex workers.
KenyaVIH/sidapublié 2008Sexually transmitted diseaseseurope_pmcdocument de 5 observationsDOI 10.1097/olq.0b013e31816907fa
178 600 000 inhabitantsIn 2000, 178.6 million (28.1%) people lived in areas of mesoendemic transmission (>10% to 50% PfPR2-10) in Africa.
Kenyapaludismeobservé 2000publié 2014Lancet (London, England)europe_pmcdocument de 4 observations
93 179 facility-records93,179 facility-records from 11,446 health facilities were extracted from DHIS2 for HIV-data in Kenya from 2011 to 2018.
KenyaVIH/sidaobservé 2011 to 2018publié 2020BMC medical informatics and decision makingPubMeddocument de 5 observations
11 countriesSustained human-to-human mpox transmission was observed in 11 countries as of February 2025: DRC, Congo Republic, Central African Republic, Burundi, Kenya, Rwanda, Uganda, Zambia, Nigeria, Liberia, and Cote d’Ivoire.
Burundi · Kenya · Liberia · Nigeria · Ouganda · RDC · Rwanda · Zambiempoxobservé February 2025Africa CDCdocument de 110 observations
0,3 personsThe microclinic intervention increased HIV status disclosure to close social supports by +0.3 persons over one year of follow-up.
KenyaVIH/sidaobservé one year of follow-uppublié 2021PloS onePubMeddocument de 9 observations
120 cm/sIn a cross-sectional study of 105 Kenyan children with sickle cell anaemia, mean cerebral blood flow velocity was 120 +/- 34.9 cm/s.
Kenyadrépanocytosepublié 2009British journal of haematologyeurope_pmcdocument de 4 observations
91,9 %Among virally suppressed AYPLHIV at baseline enrolled in Operation Triple Zero (OTZ), 91.9% of females sustained viral load suppression (VLS).
KenyaVIH/sidapublié 2025The Journal of adolescent health : official publication of the Society for Adolescent MediPubMeddocument de 9 observations
There was a significant difference in probability of non-infection during malaria episodes in the study sites, with Kombewa having the least median time of non-infection during malaria episodes.
Kenyapaludismepublié 2022Parasites & vectorsPubMeddocument de 7 observations
1 per_317Among 317 women, invasive cervical cancer cases included HPV16 in 1/317 (0.3%) and HPV81 in 3/317 (0.9%).
Kenyacancer du col de l'utéruspublié 2021BioMed research internationalPubMeddocument de 9 observations
3,6 %Among Kenyan adolescents aged 15–19 years in Kisumu, girls were more likely than boys to have used PrEP (3.6% vs. 0.3%).
KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 15 observations
0,6 %Among cases with CIN1, HPV11 was detected in 2 out of 317 participants (0.6%).
KenyaCIN1publié 2022African health sciencesPubMeddocument de 9 observations
100 %Wild Anopheles gambiae sensu lato (s.l.) and Anopheles funestus s.l. showed 100% susceptibility to broflanilide.
Kenyapaludismepublié 2025Malaria journalPubMeddocument de 6 observations
50,8 %The magnitude of any type of post-TB lung disease was 50.8% in Southern America among individuals in low- and middle-income countries.
Kenyapost-TB lung diseasepublié 2022PLOS global public healtheurope_pmcdocument de 11 observationsDOI 10.1371/journal.pgph.0000805
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.